![Cho Hee Yun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Cho Hee Yun formerly worked at Gilead Sciences, Inc., as Executive Director-Clinical Research, Ventyx Biosciences, Inc., as Vice President-Clinical Development, and Pliant Therapeutics, Inc., as Senior Vice President-Clinical Development from 2024 to 2025.
Dr. Yun received her undergraduate degree and doctorate degree from Seoul National University.
Ehemalige bekannte Positionen von Cho Hee Yun
| Unternehmen | Position | Ende |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2025 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| VENTYX BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Cho Hee Yun
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
